TipRanks
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
Want to see NEUP full AI Analyst Report?

Neuphoria Therapeutics (NEUP) Revenue

301 Followers

Neuphoria Therapeutics Revenue

Neuphoria Therapeutics had a revenue of 1.17M in the quarter ending Jun 30, 2026, with Infinity%. This bring the company's revenue in the last twelve months to 1.17M, Decreased 111.21%. In the fiscal year ending Jun 30, 2026, Neuphoria Therapeutics had annual revenue of 1.17M with -92.50% growth.
Revenue (ttm)
1.17M
Revenue Growth
―
P/S Ratio
14.10
Revenue/Employee
$1,174,165
Employees
1
Market Cap
$16.56M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 2026
1.17M-14.48M-92.50%
Jun 30, 2025
15.65M―+∞%
Jun 30, 2024
―――
Jun 30, 2023
―-383.16K-100.00%
Jun 30, 2022
383.16K-544.39K-58.69%
Jun 30, 2021
927.54K895.48K+2,792.97%
Jun 30, 2020
32.06K-7.36M-99.57%
Jun 30, 2019
7.40M-4.55M-38.08%
Jun 30, 2018
11.94M-15.20M-56.00%
Jun 30, 2017
27.15M――